株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

エポプロステノールナトリウム剤の世界市場:成長動向・競合分析

Global Epoprostenol Sodium Drugs Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

発行 QYResearch 商品コード 798063
出版日 ページ情報 英文 113 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.28円で換算しております。
Back to Top
エポプロステノールナトリウム剤の世界市場:成長動向・競合分析 Global Epoprostenol Sodium Drugs Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
出版日: 2019年03月04日 ページ情報: 英文 113 Pages
概要

当レポートでは、世界のエポプロステノールナトリウム剤の市場を調査し、市場および製品の概要、販売数・収益・価格などの推移と予測、タイプ・用途・地域別の内訳、製造・販売などの動向、市場成長への各種影響因子の分析、競合環境と市場シェア、主要製造業者のプロファイルなどをまとめています。

第1章 レポート概要

  • 調査範囲
  • 調査対象製造業者
  • 市場区分:タイプ別
    • 成長率:タイプ別
    • 0.5 mg
    • 1.5 mg
  • 市場区分:用途別
    • 市場シェア:用途別
    • 病院
    • 診療所
  • 調査対象
  • 調査対象年

第2章 世界の成長動向

  • 販売数・収益の推移・予測
  • 成長率:地域別
  • 産業動向

第3章 製造業者の市場シェア

  • 販売数・販売数のシェア:製造業者別
  • 収益・収益のシェア:製造業者別
  • 価格:製造業者別
  • 主要製造業者の工場の分布・販売エリア
  • 主要製造業者の市場参入時期
  • 主要製造業者の提供製品
  • M&A・拡張計画

第4章 市場規模の推移:タイプ別

  • 販売数・収益の推移
  • 販売数のシェア
  • 収益のシェア
  • 価格

第5章 市場規模の推移:用途別

  • 概要
  • 販売数

第6章 北米市場の分析

  • 販売数の推移:企業別
  • 販売数の推移:タイプ別
  • 販売数の推移:用途別
  • 販売数・収益の推移:国別
    • 米国
    • カナダ
    • メキシコ

第7章 欧州市場の分析

  • 販売数の推移:企業別
  • 販売数の推移:タイプ別
  • 販売数の推移:用途別
  • 販売数・収益の推移:国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋市場の分析

  • 販売数の推移:企業別
  • 販売数の推移:タイプ別
  • 販売数の推移:用途別
  • 販売数・収益の推移:国別
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • インドネシア
    • マレーシア
    • フィリピン
    • タイ
    • ベトナム

第9章 中南米市場の分析

  • 販売数の推移:企業別
  • 販売数の推移:タイプ別
  • 販売数の推移:用途別
  • 販売数・収益の推移:国別
    • ブラジル

第10章 中東・アフリカ市場の分析

  • 販売数の推移:タイプ別
  • 販売数の推移:用途別
  • 販売数・収益の推移:国別
    • GCC諸国
    • エジプト
    • 南アフリカ

第11章 企業プロファイル

  • GSK
  • Teva

第12章 バリューチェーン・販売経路の分析

第13章 市場予測

  • 販売数・収益の予測
  • 販売数の予測:タイプ別
  • 販売数の予測:用途別
  • 販売数・収益の予測:地域・国別

第14章 調査結果・総論

第15章 付録

図表

List of Tables and Figures

  • Figure Epoprostenol Sodium Drugs Product Picture
  • Table Epoprostenol Sodium Drugs Key Market Segments
  • Table Major Manufacturers Epoprostenol Sodium Drugs Covered in This Report
  • Table Global Epoprostenol Sodium Drugs Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
  • Figure Global Epoprostenol Sodium Drugs Sales Market Shar by Type 2014-2025
  • Figure 0.5 mg Figures
  • Table Major Manufacturers of 0.5 mg
  • Figure 1.5 mg Figures
  • Table Major Manufacturers of 1.5 mg
  • Table Global Epoprostenol Sodium Drugs Market Share by Application 2019-2025 (K Units)
  • Figure Hospital Use Case
  • Figure Clinic Use Case
  • Figure Epoprostenol Sodium Drugs Report Years Considered
  • Figure Global Epoprostenol Sodium Drugs Market Size 2014-2025 (Million US$)
  • Figure Global Epoprostenol Sodium Drugs Sales 2014-2019 (K Units)
  • Table Global Epoprostenol Sodium Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
  • Table Global Epoprostenol Sodium Drugs Sales by Regions 2014-2019 (K Units)
  • Table Global Epoprostenol Sodium Drugs Sales Market Share by Regions 2014-2019
  • Figure Global Epoprostenol Sodium Drugs Sales Market Share by Regions 2014-2019
  • Figure Global Epoprostenol Sodium Drugs Sales Market Share by Regions in 2018
  • Table Global Epoprostenol Sodium Drugs Revenue by Regions 2014-2019 (Million US$)
  • Table Global Epoprostenol Sodium Drugs Revenue Market Share by Regions 2014-2019
  • Figure Global Epoprostenol Sodium Drugs Revenue Market Share by Regions 2014-2019
  • Figure Global Epoprostenol Sodium Drugs Revenue Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Global Epoprostenol Sodium Drugs Sales by Manufacturers (2014-2019) (K Units)
  • Table Global Epoprostenol Sodium Drugs Sales Share by Manufacturers (2014-2019)
  • Figure Global Epoprostenol Sodium Drugs Sales Share by Manufacturers in 2018
  • Table Epoprostenol Sodium Drugs Revenue by Manufacturers (2014-2019) (Million USD)
  • Table Epoprostenol Sodium Drugs Revenue Share by Manufacturers (2014-2019)
  • Figure Epoprostenol Sodium Drugs Value Share by Manufacturers in 2019
  • Table Global Epoprostenol Sodium Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Manufacturers Epoprostenol Sodium Drugs Price (2014-2019) (USD/Unit)
  • Table Key Manufacturers Epoprostenol Sodium Drugs Plants/Factories Distribution
  • Table Key Manufacturers Epoprostenol Sodium Drugs Area Served
  • Table Date of Key Manufacturers Enter into Epoprostenol Sodium Drugs Market
  • Table Key Manufacturers Epoprostenol Sodium Drugs Product Type
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global 0.5 mg Sales and Revenue (2014-2019) (K Units) & (Million US$)
  • Table Global 1.5 mg Sales and Revenue (2014-2019) (K Units) & (Million US$)
  • Table Global Epoprostenol Sodium Drugs Sales by Type (2014-2019) (K Units)
  • Table Global Epoprostenol Sodium Drugs Sales Share by Type (2014-2019)
  • Figure Global Epoprostenol Sodium Drugs Sales Market Share by Type (2014-2019)
  • Figure Global Epoprostenol Sodium Drugs Sales Market Share by Type in 2018
  • Table Global Epoprostenol Sodium Drugs Revenue by Type (2014-2019) (Million US$)
  • Table Global Epoprostenol Sodium Drugs Revenue Share by Type (2014-2019)
  • Figure Global Epoprostenol Sodium Drugs Revenue Market Share by Type (2014-2019)
  • Figure Global Epoprostenol Sodium Drugs Revenue Market Share by Type in 2018
  • Table Epoprostenol Sodium Drugs Price by Type 2014-2019 (USD/Unit)
  • Table Global Epoprostenol Sodium Drugs Sales by Application (2014-2019) (K Units)
  • Table Global Epoprostenol Sodium Drugs Sales Share by Application (2014-2019)
  • Figure Global Sales Epoprostenol Sodium Drugs Market Share by Application (2014-2019)
  • Figure Global Sales Epoprostenol Sodium Drugs Market Share by Application in 2018
  • Figure North America Epoprostenol Sodium Drugs Sales Growth Rate 2014-2019 (K Units)
  • Figure North America Epoprostenol Sodium Drugs Revenue Growth Rate 2014-2019 (Million US$)
  • Table North America Epoprostenol Sodium Drugs Sales by Company (2014-2019) (K Units)
  • Table North America Epoprostenol Sodium Drugs Sales Market Share by Company (2014-2019)
  • Figure North America Epoprostenol Sodium Drugs Sales Market Share by Company in 2019
  • Table North America Epoprostenol Sodium Drugs Sales by Type (2014-2019) (K Units)
  • Table North America Epoprostenol Sodium Drugs Sales Market Share by Type (2014-2019)
  • Figure North America Epoprostenol Sodium Drugs Market Share by Type in 2019
  • Table North America Epoprostenol Sodium Drugs Sales by Application (2014-2019) (K Units)
  • Table North America Epoprostenol Sodium Drugs Sales Market Share by Application (2014-2019)
  • Figure North America Epoprostenol Sodium Drugs Market Share by Application in 2019
  • Table North America Epoprostenol Sodium Drugs Sales by Countries (2014-2019) (K Units)
  • Table North America Epoprostenol Sodium Drugs Sales Market Share by Countries (2014-2019)
  • Figure 2017 North America Epoprostenol Sodium Drugs Sales Market Share by Countries
  • Table North America Epoprostenol Sodium Drugs Revenue by Countries (2014-2019) (Million US$)
  • Table North America Epoprostenol Sodium Drugs Revenue Market Share by Countries (2014-2019)
  • Figure 2017 North America Epoprostenol Sodium Drugs Revenue Market Share by Countries
  • Figure United States Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Canada Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Mexico Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Europe Epoprostenol Sodium Drugs Sales Growth Rate 2014-2019 (K Units)
  • Figure Europe Epoprostenol Sodium Drugs Revenue Growth Rate 2014-2019 (Million US$)
  • Table Europe Epoprostenol Sodium Drugs Sales by Company (2014-2019) (K Units)
  • Table Europe Epoprostenol Sodium Drugs Sales Market Share by Company (2014-2019)
  • Figure Europe Epoprostenol Sodium Drugs Sales Market Share by Company in 2019
  • Table Europe Epoprostenol Sodium Drugs Sales by Type (2014-2019) (K Units)
  • Table Europe Epoprostenol Sodium Drugs Sales Market Share by Type (2014-2019)
  • Figure 2017 Europe Epoprostenol Sodium Drugs Market Share by Type
  • Table Europe Epoprostenol Sodium Drugs Sales by Application (2014-2019) (K Units)
  • Table Europe Epoprostenol Sodium Drugs Sales Market Share by Application (2014-2019)
  • Figure 2017 Europe Epoprostenol Sodium Drugs Market Share by Application
  • Table Europe Epoprostenol Sodium Drugs Sales by Countries (2014-2019) (K Units)
  • Table Europe Epoprostenol Sodium Drugs Sales Market Share by Countries (2014-2019)
  • Figure 2017 Europe Epoprostenol Sodium Drugs Sales Market Share by Countries
  • Table Europe Epoprostenol Sodium Drugs Revenue by Countries (2014-2019) (Million US$)
  • Table Europe Epoprostenol Sodium Drugs Revenue Market Share by Countries (2014-2019)
  • Figure Europe Epoprostenol Sodium Drugs Revenue Market Share by Countries in 2019
  • Figure Germany Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure France Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure UK Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Italy Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Russia Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Asia Pacific Epoprostenol Sodium Drugs Sales Growth Rate 2014-2019 (K Units)
  • Figure Asia Pacific Epoprostenol Sodium Drugs Revenue Growth Rate 2014-2019 (Million US$)
  • Table Asia Pacific Epoprostenol Sodium Drugs Sales by Company (2014-2019) (K Units)
  • Table Asia Pacific Epoprostenol Sodium Drugs Sales Market Share by Company (2014-2019)
  • Figure Asia Pacific Epoprostenol Sodium Drugs Sales Market Share by Company in 2019
  • Table Asia Pacific Epoprostenol Sodium Drugs Sales by Type (2014-2019) (K Units)
  • Table Asia Pacific Epoprostenol Sodium Drugs Sales Market Share by Type (2014-2019)
  • Figure Asia Pacific Epoprostenol Sodium Drugs Market Share by Type in 2019
  • Table Asia Pacific Epoprostenol Sodium Drugs Sales by Application (2014-2019) (K Units)
  • Table Asia Pacific Epoprostenol Sodium Drugs Sales Market Share by Application (2014-2019)
  • Figure Asia Pacific Epoprostenol Sodium Drugs Market Share by Application in 2019
  • Table Asia Pacific Epoprostenol Sodium Drugs Sales by Countries (2014-2019) (K Units)
  • Table Asia Pacific Epoprostenol Sodium Drugs Sales Market Share by Countries (2014-2019)
  • Figure 2017 Asia Pacific Epoprostenol Sodium Drugs Sales Market Share by Countries
  • Table Asia Pacific Epoprostenol Sodium Drugs Revenue by Countries (2014-2019) (Million US$)
  • Table Asia Pacific Epoprostenol Sodium Drugs Revenue Market Share by Countries (2014-2019)
  • Figure 2017 Asia Pacific Epoprostenol Sodium Drugs Revenue Market Share by Countries
  • Figure China Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure China Epoprostenol Sodium Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Japan Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Japan Epoprostenol Sodium Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Korea Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Korea Epoprostenol Sodium Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure India Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure India Epoprostenol Sodium Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Australia Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Australia Epoprostenol Sodium Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Indonesia Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Indonesia Epoprostenol Sodium Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Malaysia Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Malaysia Epoprostenol Sodium Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Philippines Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Philippines Epoprostenol Sodium Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Thailand Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Thailand Epoprostenol Sodium Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Vietnam Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Vietnam Epoprostenol Sodium Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Central & South America Epoprostenol Sodium Drugs Sales Growth Rate 2014-2019 (K Units)
  • Figure Central & South America Epoprostenol Sodium Drugs Revenue Growth Rate 2014-2019 (Million US$)
  • Table Central & South America Epoprostenol Sodium Drugs Sales by Company (2014-2019) (K Units)
  • Table Central & South America Epoprostenol Sodium Drugs Sales Market Share by Company (2014-2019)
  • Figure Central & South America Epoprostenol Sodium Drugs Sales Market Share by Company in 2018
  • Table Central & South America Epoprostenol Sodium Drugs Sales by Type (2014-2019) (K Units)
  • Table Central & South America Epoprostenol Sodium Drugs Sales Market Share by Type (2014-2019)
  • Figure Central & South America Epoprostenol Sodium Drugs Market Share by Type in 2019
  • Table Central & South America Epoprostenol Sodium Drugs Sales by Application (2014-2019) (K Units)
  • Table Central & South America Epoprostenol Sodium Drugs Sales Market Share by Application (2014-2019)
  • Figure Central & South America Epoprostenol Sodium Drugs Market Share by Application in 2019
  • Table Central & South America Epoprostenol Sodium Drugs Sales by Countries (2014-2019) (K Units)
  • Table Central & South America Epoprostenol Sodium Drugs Sales Market Share by Countries (2014-2019)
  • Figure Central & South America Epoprostenol Sodium Drugs Sales Market Share by Countries in 2019
  • Table Central & South America Epoprostenol Sodium Drugs Revenue by Countries (2014-2019) (Million US$)
  • Table Central & South America Epoprostenol Sodium Drugs Revenue Market Share by Countries (2014-2019)
  • Figure Central & South America Epoprostenol Sodium Drugs Revenue Market Share by Countries in 2019
  • Figure Brazil Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Brazil Epoprostenol Sodium Drugs Revenue Growth Rate (2014-2019) (K Units)
  • Figure Middle East and Africa Epoprostenol Sodium Drugs Sales Growth Rate 2014-2019 (K Units)
  • Figure Middle East and Africa Epoprostenol Sodium Drugs Revenue Growth Rate 2014-2019 (Million US$)
  • Table Middle East and Africa Epoprostenol Sodium Drugs Sales by Type (2014-2019) (K Units)
  • Table Middle East and Africa Epoprostenol Sodium Drugs Sales Market Share by Type (2014-2019)
  • Figure 2017 Middle East and Africa Epoprostenol Sodium Drugs Market Share by Type
  • Table Middle East and Africa Epoprostenol Sodium Drugs Sales by Application (2014-2019) (K Units)
  • Table Middle East and Africa Epoprostenol Sodium Drugs Sales Market Share by Application (2014-2019)
  • Figure 2017 Middle East and Africa Epoprostenol Sodium Drugs Market Share by Application
  • Table Middle East and Africa Epoprostenol Sodium Drugs Sales by Countries (2014-2019) (K Units)
  • Table Middle East and Africa Epoprostenol Sodium Drugs Sales Market Share by Countries (2014-2019)
  • Figure 2017 Middle East and Africa Epoprostenol Sodium Drugs Sales Market Share by Countries
  • Table Middle East and Africa Epoprostenol Sodium Drugs Revenue by Countries (2014-2019) (Million US$)
  • Table Middle East and Africa Epoprostenol Sodium Drugs Revenue Market Share by Countries (2014-2019)
  • Figure 2017 Middle East and Africa Epoprostenol Sodium Drugs Revenue Market Share by Countries
  • Figure GCC Countries Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure GCC Countries Epoprostenol Sodium Drugs Revenue Growth Rate (2014-2019) (K Units)
  • Figure Egypt Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Egypt Epoprostenol Sodium Drugs Revenue Growth Rate (2014-2019) (K Units)
  • Figure South Africa Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure South Africa Epoprostenol Sodium Drugs Revenue Growth Rate (2014-2019) (K Units)
  • Table GSK Company Details
  • Table GSK Description and Business Overview
  • Table GSK Epoprostenol Sodium Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table GSK Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019)
  • Table GSK Epoprostenol Sodium Drugs Sales Market Share in Global Market
  • Table GSK Recent Development
  • Table Teva Company Details
  • Table Teva Description and Business Overview
  • Table Teva Epoprostenol Sodium Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Teva Epoprostenol Sodium Drugs Sales Growth Rate (2014-2019)
  • Table Teva Epoprostenol Sodium Drugs Sales Market Share in Global Market
  • Table Teva Recent Development
  • Figure Epoprostenol Sodium Drugs Value Chain
  • Table Epoprostenol Sodium Drugs Distributors List
  • Table Epoprostenol Sodium Drugs Customers List
  • Table Global Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units) & (Million US$)
  • Figure Global Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Global Epoprostenol Sodium Drugs Revenue Forecast 2019-2025 (Million US$)
  • Table Global Epoprostenol Sodium Drugs Sales Forecast by Type 2019-2025 (K Units)
  • Figure Global Epoprostenol Sodium Drugs Sales Forecast by Type 2019-2025 (K Units)
  • Figure Global Epoprostenol Sodium Drugs Sales Market Share Forecast by Type 2019-2025
  • Table Global Epoprostenol Sodium Drugs Sales Forecast by Application 2019-2025 (K Units)
  • Figure Global Epoprostenol Sodium Drugs Sales Forecast by Application 2019-2025 (K Units)
  • Figure Global Epoprostenol Sodium Drugs Sales Market Share Forecast by Application 2019-2025
  • Table Global Epoprostenol Sodium Drugs Sales Forecast by Regions 2019-2025 (K Units)
  • Figure Global Epoprostenol Sodium Drugs Sales Forecast by Regions 2019-2025 (K Units)
  • Figure Global Epoprostenol Sodium Drugs Sales Market Share Forecast by Regions 2019-2025
  • Table Global Epoprostenol Sodium Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
  • Figure Global Epoprostenol Sodium Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
  • Figure Global Epoprostenol Sodium Drugs Revenue Market Share Forecast by Regions 2019-2025
  • Table North America Epoprostenol Sodium Drugs Sales Forecast by Countries 2019-2025 (K Units)
  • Table North America Epoprostenol Sodium Drugs Sales Market Share Forecast by Countries 2019-2025
  • Table North America Epoprostenol Sodium Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
  • Table North America Epoprostenol Sodium Drugs Revenue Market Share Forecast by Countries 2019-2025
  • Figure United States Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Canada Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure MexicoEpoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Table Europe Epoprostenol Sodium Drugs Sales Forecast by Countries 2019-2025 (K Units)
  • Table Europe Epoprostenol Sodium Drugs Sales Market Share Forecast by Countries 2019-2025
  • Table Europe Epoprostenol Sodium Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
  • Table Europe Epoprostenol Sodium Drugs Revenue Market Share Forecast by Countries 2019-2025
  • Figure Germany Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure France Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure UK Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Italy Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Russia Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Table Asia Pacific Epoprostenol Sodium Drugs Sales Forecast by Countries 2019-2025 (K Units)
  • Table Asia Pacific Epoprostenol Sodium Drugs Sales Market Share Forecast by Countries 2019-2025
  • Table Asia Pacific Epoprostenol Sodium Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
  • Table Asia Pacific Epoprostenol Sodium Drugs Revenue Market Share Forecast by Countries 2019-2025
  • Figure China Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Japan Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Korea Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure India Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Australia Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Indonesia Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Thailand Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Malaysia Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Philippines Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Vietnam Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Table Central & South America Epoprostenol Sodium Drugs Sales Forecast by Countries 2019-2025 (K Units)
  • Table Central & South America Epoprostenol Sodium Drugs Sales Market Share Forecast by Countries 2019-2025
  • Table Central & South America Epoprostenol Sodium Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
  • Table Central & South America Epoprostenol Sodium Drugs Revenue Market Share Forecast by Countries 2019-2025
  • Figure Brazil Epoprostenol Sodium Drugs Sales Forecast 2019-2025 (K Units)
  • Table Middle East and Africa Epoprostenol Sodium Drugs Sales Forecast by Regions 2019-2025 (K Units)
  • Table Middle East and Africa Epoprostenol Sodium Drugs Sales Market Share Forecast by Regions 2019-2025
  • Table Middle East and Africa Epoprostenol Sodium Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
  • Table Middle East and Africa Epoprostenol Sodium Drugs Revenue Market Share Forecast by Regions 2019-2025
  • Figure GCC Countries Epoprostenol Sodium Drugs Sales Growth Rate (2019-2025) (K Units)
  • Figure Egypt Epoprostenol Sodium Drugs Sales Growth Rate (2019-2025) (K Units)
  • Figure South Africa Epoprostenol Sodium Drugs Sales Growth Rate (2019-2025) (K Units)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
目次

Epoprostenol sodium directly simulates prostaglandin receptors in arterial vascular smooth muscle, thereby causing vasodilatation.

In 2018, the global Epoprostenol Sodium Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Epoprostenol Sodium Drugs.

This study researches the market size of Epoprostenol Sodium Drugs, presents the global Epoprostenol Sodium Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.

This report focuses on the key data information of Epoprostenol Sodium Drugs in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Epoprostenol Sodium Drugs for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.

  • GSK
  • Teva

Market Segment by Product Type

  • 0.5 mg
  • 1.5 mg

Market Segment by Application

  • Hospital
  • Clinic

Market size split by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
    • Rest of Central & South America
  • Middle East & Africa
    • GCC Countries
    • Egypt
    • South Africa

The study objectives are:

  • To analyze and research the global Epoprostenol Sodium Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Epoprostenol Sodium Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Epoprostenol Sodium Drugs are as follows:

  • History Year: 2014-2019
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

Table of Contents

1. Report Overview

  • 1.1. Research Scope
  • 1.2. Major Manufacturers Covered in This Report
  • 1.3. Market Segment by Type
    • 1.3.1. Global Epoprostenol Sodium Drugs Market Size Growth Rate by Type
    • 1.3.2. 0.5 mg
    • 1.3.3. 1.5 mg
  • 1.4. Market Segment by Application
    • 1.4.1. Global Epoprostenol Sodium Drugs Market Share by Application (2018-2025)
    • 1.4.2. Hospital
    • 1.4.3. Clinic
  • 1.5. Study Objectives
  • 1.6. Years Considered

2. Global Growth Trends

  • 2.1. Global Epoprostenol Sodium Drugs Market Size
    • 2.1.1. Global Epoprostenol Sodium Drugs Revenue 2014-2025
    • 2.1.2. Global Epoprostenol Sodium Drugs Sales 2014-2025
  • 2.2. Epoprostenol Sodium Drugs Growth Rate by Regions
    • 2.2.1. Global Epoprostenol Sodium Drugs Sales by Regions 2014-2019
    • 2.2.2. Global Epoprostenol Sodium Drugs Revenue by Regions 2014-2019
  • 2.3. Industry Trends
    • 2.3.1. Market Top Trends
    • 2.3.2. Market Drivers

3. Market Share by Manufacturers

  • 3.1. Epoprostenol Sodium Drugs Sales by Manufacturers
    • 3.1.1. Epoprostenol Sodium Drugs Sales by Manufacturers 2014-2019
    • 3.1.2. Epoprostenol Sodium Drugs Sales Market Share by Manufacturers 2014-2019
  • 3.2. Revenue by Manufacturers
    • 3.2.1. Epoprostenol Sodium Drugs Revenue by Manufacturers (2014-2019)
    • 3.2.2. Epoprostenol Sodium Drugs Revenue Share by Manufacturers (2014-2019)
    • 3.2.3. Global Epoprostenol Sodium Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.3. Epoprostenol Sodium Drugs Price by Manufacturers
  • 3.4. Key Manufacturers Epoprostenol Sodium Drugs Plants/Factories Distribution and Area Served
  • 3.5. Date of Key Manufacturers Enter into Epoprostenol Sodium Drugs Market
  • 3.6. Key Manufacturers Epoprostenol Sodium Drugs Product Offered
  • 3.7. Mergers & Acquisitions, Expansion Plans

4. Market Size by Type

  • 4.1. Sales and Revenue for Each Type
    • 4.1.1. 0.5 mg Sales and Revenue (2014-2019)
    • 4.1.2. 1.5 mg Sales and Revenue (2014-2019)
  • 4.2. Global Epoprostenol Sodium Drugs Sales Market Share by Type
  • 4.3. Global Epoprostenol Sodium Drugs Revenue Market Share by Type
  • 4.4. Epoprostenol Sodium Drugs Price by Type

5. Market Size by Application

  • 5.1. Overview
  • 5.2. Global Epoprostenol Sodium Drugs Sales by Application

6. North America

  • 6.1. North America Epoprostenol Sodium Drugs Breakdown Data by Company
  • 6.2. North America Epoprostenol Sodium Drugs Breakdown Data by Type
  • 6.3. North America Epoprostenol Sodium Drugs Breakdown Data by Application
  • 6.4. North America Epoprostenol Sodium Drugs Breakdown Data by Countries
    • 6.4.1. North America Epoprostenol Sodium Drugs Sales by Countries
    • 6.4.2. North America Epoprostenol Sodium Drugs Revenue by Countries
    • 6.4.3. United States
    • 6.4.4. Canada
    • 6.4.5. Mexico

7. Europe

  • 7.1. Europe Epoprostenol Sodium Drugs Breakdown Data by Company
  • 7.2. Europe Epoprostenol Sodium Drugs Breakdown Data by Type
  • 7.3. Europe Epoprostenol Sodium Drugs Breakdown Data by Application
  • 7.4. Europe Epoprostenol Sodium Drugs Breakdown Data by Countries
    • 7.4.1. Europe Epoprostenol Sodium Drugs Sales by Countries
    • 7.4.2. Europe Epoprostenol Sodium Drugs Revenue by Countries
    • 7.4.3. Germany
    • 7.4.4. France
    • 7.4.5. UK
    • 7.4.6. Italy
    • 7.4.7. Russia

8. Asia Pacific

  • 8.1. Asia Pacific Epoprostenol Sodium Drugs Breakdown Data by Company
  • 8.2. Asia Pacific Epoprostenol Sodium Drugs Breakdown Data by Type
  • 8.3. Asia Pacific Epoprostenol Sodium Drugs Breakdown Data by Application
  • 8.4. Asia Pacific Epoprostenol Sodium Drugs Breakdown Data by Countries
    • 8.4.1. Asia Pacific Epoprostenol Sodium Drugs Sales by Countries
    • 8.4.2. Asia Pacific Epoprostenol Sodium Drugs Revenue by Countries
    • 8.4.3. China
    • 8.4.4. Japan
    • 8.4.5. Korea
    • 8.4.6. India
    • 8.4.7. Australia
    • 8.4.8. Indonesia
    • 8.4.9. Malaysia
    • 8.4.10. Philippines
    • 8.4.11. Thailand
    • 8.4.12. Vietnam

9. Central & South America

  • 9.1. Central & South America Epoprostenol Sodium Drugs Breakdown Data by Company
  • 9.2. Central & South America Epoprostenol Sodium Drugs Breakdown Data by Type
  • 9.3. Central & South America Epoprostenol Sodium Drugs Breakdown Data by Application
  • 9.4. Central & South America Epoprostenol Sodium Drugs Breakdown Data by Countries
    • 9.4.1. Central & South America Epoprostenol Sodium Drugs Sales by Countries
    • 9.4.2. Central & South America Epoprostenol Sodium Drugs Revenue by Countries
    • 9.4.3. Brazil

10. Middle East and Africa

  • 10.1. Middle East and Africa Epoprostenol Sodium Drugs Breakdown Data by Type
  • 10.2. Middle East and Africa Epoprostenol Sodium Drugs Breakdown Data by Application
  • 10.3. Middle East and Africa Epoprostenol Sodium Drugs Breakdown Data by Countries
    • 10.3.1. Middle East and Africa Epoprostenol Sodium Drugs Sales by Countries
    • 10.3.2. Middle East and Africa Epoprostenol Sodium Drugs Revenue by Countries
    • 10.3.3. GCC Countries
    • 10.3.4. Egypt
    • 10.3.5. South Africa

11. Company Profiles

  • 11.1. GSK
    • 11.1.1. GSK Company Details
    • 11.1.2. Company Description and Business Overview
    • 11.1.3. Sales, Revenue and Market Share of Epoprostenol Sodium Drugs
    • 11.1.4. Epoprostenol Sodium Drugs Product Introduction
    • 11.1.5. GSK Recent Development
  • 11.2. Teva
    • 11.2.1. Teva Company Details
    • 11.2.2. Company Description and Business Overview
    • 11.2.3. Sales, Revenue and Market Share of Epoprostenol Sodium Drugs
    • 11.2.4. Epoprostenol Sodium Drugs Product Introduction
    • 11.2.5. Teva Recent Development

12. Value Chain and Sales Channels Analysis

  • 12.1. Value Chain Analysis
  • 12.2. Sales Channels Analysis
    • 12.2.1. Epoprostenol Sodium Drugs Sales Channels
    • 12.2.2. Epoprostenol Sodium Drugs Distributors
  • 12.3. Epoprostenol Sodium Drugs Customers

13. Market Forecast

  • 13.1. Global Epoprostenol Sodium Drugs Sales and Revenue Forecast 2019-2025
  • 13.2. Global Epoprostenol Sodium Drugs Sales Forecast by Type
  • 13.3. Global Epoprostenol Sodium Drugs Sales Forecast by Application
  • 13.4. Epoprostenol Sodium Drugs Forecast by Regions
    • 13.4.1. Global Epoprostenol Sodium Drugs Sales Forecast by Regions 2019-2025
    • 13.4.2. Global Epoprostenol Sodium Drugs Revenue Forecast by Regions 2019-2025
  • 13.5. North America Market Forecast
    • 13.5.1. North America Epoprostenol Sodium Drugs Forecast by Countries 2019-2025
    • 13.5.2. United States
    • 13.5.3. Canada
    • 13.5.4. Mexico
  • 13.6. Europe Market Forecast
    • 13.6.1. Europe Epoprostenol Sodium Drugs Forecast by Countries 2019-2025
    • 13.6.2. Germany
    • 13.6.3. France
    • 13.6.4. UK
    • 13.6.5. Italy
    • 13.6.6. Russia
  • 13.7. Asia Pacific Market Forecast
    • 13.7.1. Asia Pacific Epoprostenol Sodium Drugs Sales Forecast by Countries 2019-2025
    • 13.7.2. China
    • 13.7.3. Japan
    • 13.7.4. Korea
    • 13.7.5. India
    • 13.7.6. Australia
    • 13.7.7. Indonesia
    • 13.7.8. Thailand
    • 13.7.9. Malaysia
    • 13.7.10. Philippines
    • 13.7.11. Vietnam
  • 13.8. Central & South America Market Forecast
    • 13.8.1. Central & South America Epoprostenol Sodium Drugs Sales Forecast by Countries 2019-2025
    • 13.8.2. Brazil
  • 13.9. Middle East and Africa Market Forecast
    • 13.9.1. Middle East and Africa Epoprostenol Sodium Drugs Sales Forecast by Countries 2019-2025
    • 13.9.2. GCC Countries
    • 13.9.3. Egypt
    • 13.9.4. South Africa

14. Research Findings and Conclusion

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Methodology/Research Approach
      • 15.1.1.1. Research Programs/Design
      • 15.1.1.2. Market Size Estimation
      • 15.1.1.3. Market Breakdown and Data Triangulation
    • 15.1.2. Data Source
      • 15.1.2.1. Secondary Sources
      • 13.1.2.2. Primary Sources
  • 15.2. Author Details
  • 15.3. Disclaimer
Back to Top